The DPM3 gene encodes the third subunit of the dolichol-phosphate mannose (DPM) synthase complex, which is essential for protein N-glycosylation and glycolipid biosynthesis [@dolicholphosphate]. DPM3 plays a crucial role in maintaining the proper function of the DPM complex, which consists of DPM1 (catalytic subunit), DPM2 (regulatory subunit), and DPM3 (scaffold subunit) [@dpm].
Dolichol-Phosphate Mannose Synthesis
The DPM synthase complex catalyzes the synthesis of dolichol-phosphate mannose (DPM), a critical donor substrate for:
N-linked Protein Glycosylation: Transfer of mannose to nascent polypeptides in the endoplasmic reticulum
Glycolipid Biosynthesis: Synthesis of glycosylphosphatidylinositol (GPI) anchors
C-mannosylation: Rare type of protein glycosylation
Neurological Function
Proper glycosylation is essential for neuronal function:
Synaptic Proteins: Many synaptic receptors and adhesion molecules require proper glycosylation
Ion Channel Function: Glycosylation affects ion channel trafficking and function
Neuronal Development: Glycosylation patterns influence neuronal migration and connectivity
Role in Neurodegenerative Diseases
Alzheimer's Disease
DPM3 and the glycosylation pathway have been implicated in Alzheimer's disease:
APP Processing: Glycosylation affects [amyloid precursor protein](/entities/app-protein) (APP) processing and [amyloid-beta](/proteins/amyloid-beta) production [@glycosylation]
[Tau](/proteins/tau) Glycosylation: Abnormal glycosylation patterns have been observed in tauopathies
Synaptic Glycoproteins: Disrupted glycosylation of synaptic proteins may contribute to synaptic loss
ER Stress: Impaired glycosylation can trigger [unfolded protein response](/entities/unfolded-protein-response) (UPR)
Parkinson's Disease
[Alpha-Synuclein](/proteins/alpha-synuclein) Glycosylation: Glycosylation patterns may affect alpha-synuclein aggregation and toxicity [@alphasynuclein]
Dopaminergic Neuron Vulnerability: Glycosylation defects may contribute to dopaminergic neuron susceptibility
ER Homeostasis: Disrupted protein quality control mechanisms
Congenital Disorders of Glycosylation
DPM3 mutations cause Congenital Disorder of Glycosylation Type Ie (CDG-Ie), characterized by: